Sign in
Factors Predicting Vitreous Hemorrhage or Neovascularization after Pan-Retinal Photocoagulation in Proliferative Diabetic Retinopathy
Jose Davila, MD
Updates from the Field
2020
Percentage of Patients Maintained on Quarterly Anti-VEGF Dosing for the Treatment of Neovascular Age-Related Macular Degeneration
David A. Eichenbaum, MD, FASRS
2018
Three-Year Outcomes of the PALADIN Phase IV Study: Comparison of Anatomical Metrics, Efficacy, and Treatment Burden Post FAc
Christopher D. Riemann, MD
Annual Meeting Talks
2022
Category: Diabetic Retinopathy